Cargando…

White matter microstructure associations to amyloid burden in adults with Down syndrome

INTRODUCTION: Individuals with Down syndrome (DS) are at an increased risk of developing Alzheimer’s Disease (AD). One of the early underlying mechanisms in AD pathology is the accumulation of amyloid protein plaques, which are deposited in extracellular gray matter and signify the first stage in th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bazydlo, Austin M., Zammit, Matthew D., Wu, Minjie, Lao, Patrick J., Dean, Douglas C., Johnson, Sterling C., Tudorascu, Dana L., Cohen, Ann, Cody, Karly A., Ances, Beau, Laymon, Charles M., Klunk, William E., Zaman, Shahid, Handen, Benjamin L., Hartley, Sigan L., Alexander, Andrew L., Christian, Bradley T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8672096/ https://www.ncbi.nlm.nih.gov/pubmed/34902714 http://dx.doi.org/10.1016/j.nicl.2021.102908

Ejemplares similares

White matter microstructure associations with episodic memory in adults with Down syndrome: a tract-based spatial statistics study
por: Bazydlo, Austin, et al.
Publicado: (2021)

PET measurement of longitudinal amyloid load identifies the earliest stages of amyloid-beta accumulation during Alzheimer’s disease progression in Down syndrome
por: Zammit, Matthew D., et al.
Publicado: (2021)

Role of tau deposition in early cognitive decline in Down syndrome
por: Hartley, Sigan L., et al.
Publicado: (2022)

Amyloid accumulation in Down syndrome measured with amyloid load
por: Zammit, Matthew D., et al.
Publicado: (2020)

Cognitive indicators of transition to preclinical and prodromal stages of Alzheimer's disease in Down syndrome
por: Hartley, Sigan L., et al.
Publicado: (2020)

Neurofibrillary tau depositions emerge with subthreshold cerebral beta-amyloidosis in down syndrome
por: Zammit, Matthew D., et al.
Publicado: (2021)

Patterns of glucose hypometabolism in Down syndrome resemble sporadic Alzheimer's disease except for the putamen
por: Zammit, Matthew D., et al.
Publicado: (2021)

Relationship of amyloid beta and neurofibrillary tau deposition in Neurodegeneration in Aging Down Syndrome (NiAD) study at baseline
por: Tudorascu, DL, et al.
Publicado: (2020)

Imaging neurodegeneration in Down syndrome: brain templates for amyloid burden and tissue segmentation
por: Lao, Patrick J., et al.
Publicado: (2018)

Sleep and White Matter in Adults with Down Syndrome
por: Fleming, Victoria, et al.
Publicado: (2021)

Timing of Alzheimer’s Disease by Intellectual Disability Level in Down Syndrome
por: Hartley, Sigan L., et al.
Publicado: (2023)

Cortical atrophy and amyloid and tau deposition in Down syndrome: A longitudinal study
por: Padilla, Concepcion, et al.
Publicado: (2022)

Amyloid- β and tau deposition influences cognitive and functional decline in Down syndrome
por: Grigorova, Monika, et al.
Publicado: (2022)

Physical activity, memory function, and hippocampal volume in adults with Down syndrome
por: Peven, Jamie C., et al.
Publicado: (2022)

The Alzheimer's Biomarker Consortium‐Down Syndrome: Rationale and methodology
por: Handen, Benjamin L., et al.
Publicado: (2020)

Detection of Brain Tau Pathology in Down Syndrome Using Plasma Biomarkers
por: Janelidze, Shorena, et al.
Publicado: (2022)

Longitudinal changes in amyloid positron emission tomography and volumetric magnetic resonance imaging in the nondemented Down syndrome population
por: Lao, Patrick J., et al.
Publicado: (2017)

Acute Regression in Down Syndrome
por: Handen, Benjamin, et al.
Publicado: (2021)

Statistical Methods for Processing Neuroimaging Data from Two Different Sites with a Down Syndrome Population Application
por: Minhas, Davneet S., et al.
Publicado: (2020)

Impact of the COVID-19 pandemic on daily life, mood, and behavior of adults with Down syndrome
por: Hartley, Sigan L., et al.
Publicado: (2022)

Support vector machine learning and diffusion-derived structural networks predict amyloid quantity and cognition in adults with Down’s syndrome
por: Brown, Stephanie S.G., et al.
Publicado: (2022)

Characterization of point-spread function specification error on Geometric Transfer Matrix partial volume correction in [(11)C]PiB amyloid imaging
por: Laymon, Charles M., et al.
Publicado: (2021)

The use of Centiloids for applying [(11)C]PiB classification cutoffs across region-of-interest delineation methods
por: Tudorascu, Dana L., et al.
Publicado: (2018)

A modified Cued Recall Test for detecting prodromal AD in adults with Down syndrome
por: Krinsky‐McHale, Sharon J., et al.
Publicado: (2022)

Longitudinal trajectories of amyloid deposition, cortical thickness, and tau in Down syndrome: A deep-phenotyping case report
por: Mak, Elijah, et al.
Publicado: (2019)

Cerebrospinal fluid biomarkers of Alzheimer's disease in a cohort of adults with Down syndrome
por: Henson, Rachel L., et al.
Publicado: (2020)

Proteomic profiles for Alzheimer's disease and mild cognitive impairment among adults with Down syndrome spanning serum and plasma: An Alzheimer's Biomarker Consortium–Down Syndrome (ABC–DS) study
por: Petersen, Melissa E., et al.
Publicado: (2020)

Markers of early changes in cognition across cohorts of adults with Down syndrome at risk of Alzheimer's disease
por: Aschenbrenner, Andrew J., et al.
Publicado: (2021)

Associations between NIH Toolbox Cognition Battery and in vivo brain amyloid and tau pathology in non‐demented older adults
por: Snitz, Beth E., et al.
Publicado: (2020)

Obstructive sleep apnea, cerebrovascular disease, and amyloid in older adults with Down syndrome across the Alzheimer’s continuum
por: Lao, Patrick, et al.
Publicado: (2022)

Adaptation of the Clinical Dementia Rating Scale for adults with Down syndrome
por: Lessov-Schlaggar, Christina N., et al.
Publicado: (2019)

Metabolic correlates of prevalent mild cognitive impairment and Alzheimer's disease in adults with Down syndrome
por: Mapstone, Mark, et al.
Publicado: (2020)

Assessing general cognitive and adaptive abilities in adults with Down syndrome: a systematic review
por: Hamburg, Sarah, et al.
Publicado: (2019)

The pattern of amyloid accumulation in the brains of adults with Down syndrome
por: Annus, Tiina, et al.
Publicado: (2016)

Trajectory of clinical symptoms in relation to amyloid chronicity
por: Birdsill, Alex C., et al.
Publicado: (2022)

Impact of partial volume correction on the regional correspondence between in vivo [C-11]PiB PET and postmortem measures of Aβ load
por: Minhas, Davneet S., et al.
Publicado: (2018)

Amyloid duration is associated with preclinical cognitive decline and tau PET
por: Koscik, Rebecca L., et al.
Publicado: (2020)

Cerebrovascular stiffness and flow dynamics in the presence of amyloid and tau biomarkers
por: Rivera‐Rivera, Leonardo A., et al.
Publicado: (2021)

Amyloid and tau imaging biomarkers explain cognitive decline from late middle-age
por: Betthauser, Tobey J, et al.
Publicado: (2020)

Cross-sectional and longitudinal atrophy is preferentially associated with tau rather than amyloid β positron emission tomography pathology
por: Gordon, Brian A., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_b4jtcsn4obqjjfroa4a7mg5lbt